The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pharmacology

• Publication date

  2017-11-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.ejphar.2017.09.043PMID 28978455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ayurvedic Medicinal Plants

  2018cited by this paper
• Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice

  2017cited by this paper
• Studies on the interaction between vanillin and β-Amyloid protein via fluorescence spectroscopy and atomic force microscopy

  2016cited by this paper
• Failed Alzheimer’s trial does not kill leading theory of disease

  2016cited by this paper
• PASS assisted prediction and pharmacological evaluation of hesperidin against scopolamine induced amnesia in mice.

  2016cited by this paper
• Uleine Disrupts Key Enzymatic and Non-Enzymatic Biomarkers that Leads to Alzheimer's Disease.

  2016cited by this paper
• The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease

  2016cited by this paper
• Antiamnesic Effects of Walnuts Consumption on Scopolamine-Induced Memory Impairments in Rats

  2015cited by this paper
• Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants

  2015cited by this paper
• Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin

  2015cited by this paper
• In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract.

  2014cited by this paper
• BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos

  2014cited by this paper
• Cognitive Enhancing and Neuroprotective Effect of the Embryo of the Nelumbo nucifera Seed

  2014cited by this paper
• Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

  2014cited by this paper
• Therapeutic Effects of Curcumin on Alzheimer's Disease

  2014cited by this paper
• Tau aggregation and its interplay with amyloid-β

  2014cited by this paper
• 2014 Alzheimer's disease facts and figures

  2014cited by this paper
• Acetylcholinesterase Inhibitors as Alzheimer Therapy: From Nerve Toxins to Neuroprotection

  2014influential reference
• The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

  2014cited by this paper
• Beneficial effect of aqueous root extract of Glycyrrhiza glabra on learning and memory using different behavioral models: An experimental study

  2013cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease

  2013cited by this paper
• Monetary costs of dementia in the United States.

  2013cited by this paper
• Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.

  2013cited by this paper
• Serrapeptase and nattokinase intervention for relieving Alzheimer’s disease pathophysiology in rat model

  2013cited by this paper
• Monetary costs of dementia in the United States.

  2013cited by this paper
• Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo

  2012cited by this paper
• The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction

  2012cited by this paper
• N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

  2012cited by this paper
• Medicinal plants with a potential to treat Alzheimer and associated symptoms

  2012cited by this paper
• Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease.

  2012cited by this paper
• Ayurvedic medicinal plants for Alzheimer's disease: a review

  2012cited by this paper
• Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)

  2011cited by this paper
• New Acetylcholinesterase Inhibitors for Alzheimer's Disease

  2011cited by this paper
• Improvement of Cognitive Deficit in Alzheimer’s Disease Patients by Long Term Treatment with Korean Red Ginseng

  2011cited by this paper
• Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues

  2011cited by this paper
• Kinetics of acetylcholinesterase inhibition by an aqueous extract of Withania somnifera roots

  2011cited by this paper
• A phase II trial of huperzine A in mild to moderate Alzheimer disease

  2011cited by this paper
• Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.

  2010cited by this paper
• Acetylcholinesterase Inhibitory Activity of Uleine from Himatanthus lancifolius

  2010cited by this paper
• Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats

  2010cited by this paper
• Neuropathology of Alzheimer's disease.

  2010cited by this paper
• Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta‐amyloid‐induced toxicity in PC12 cells

  2010cited by this paper
• Why Did Tarenflurbil Fail in Alzheimer's Disease?

  2009cited by this paper
• Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Role of Ocimum sanctum in the experimental model of Alzheimer’s disease in rats

  2009cited by this paper
• Tramiprosate (Alzhemed) for Alzheimer's disease

  2009cited by this paper
• Getting the iron out: phlebotomy for Alzheimer's disease?

  2009cited by this paper
• The effect of curcumin (turmeric) on Alzheimer's disease: An overview

  2008cited by this paper
• Panax Ginseng Enhances Cognitive Performance in Alzheimer Disease

  2008cited by this paper
• Effect of Glabridin from Glycyrrhiza glabra on Learning and Memory in Mice

  2008cited by this paper
• Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men

  2008cited by this paper
• Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!

  2006cited by this paper
• Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.

  2006cited by this paper
• Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias

  2005cited by this paper
• The Interplay of Neurotransmitters in Alzheimer's Disease

  2005cited by this paper
• Neuropathology of Alzheimer’s Disease

  2004cited by this paper
• NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer's and vascular dementia.

  2004cited by this paper
• Acetylcholinesterase inhibitors: novel activities of old molecules.

  2004cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders

  2003cited by this paper
• EFFECT OF TINOSPORA CORDIFOLIA ON LEARNING AND MEMORY IN NORMAL AND MEMORY DEFICIT RATS

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Nutritional approaches to combat oxidative stress in Alzheimer's disease.

  2002cited by this paper
• Protective effect of Acorus calamus against acrylamide induced neurotoxicity

  2002cited by this paper
• Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.

  2000cited by this paper
• Acetylcholinesterase inhibitors for Alzheimer's disease

  1999cited by this paper
• Acetylcholinesterase inhibitors in Alzheimer's disease.

  1999cited by this paper
• Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils

  1998cited by this paper
• Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

  1997cited by this paper
• EUROPEAN HERBS WITH CHOLINERGIC ACTIVITIES: POTENTIAL IN DEMENTIA THERAPY

  1996cited by this paper
• Use of Phosphatidylserine in Alzheimer's Disease

  1991cited by this paper
• Central nervous system studies on an ethanol extract of Acorus calamus rhizomes.

  1990cited by this paper
• Central Nervous System Studies

  1989cited by this paper
• Emerging Biomarkers in Alzheimer’s Disease (Recent Update)

  1969cited by this paper

• Targeted Nanodelivery of WGX50 and Curcumin via Gold Nanoparticles for Alzheimer's Therapy

  2026cites this paper
• Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease

  2025cites this paper
• A Novel Oxo‐Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease

  2025cites this paper
• A meta-analysis update evaluating the treatment effects of donepezil alone versus donepezil combined with memantine for Alzheimer's disease

  2025cites this paper
• The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil

  2025cites this paper
• Nobiletin Ameliorates Aβ1–42‐Induced Cognitive Disorder and Mitochondrial Dysfunction via Targeting the Key Circadian Regulator Bmal1

  2025cites this paper
• The evaluation of potential triple enzyme inhibition and antioxidant activities of novel series 2-(benzo[d]thiazol-2-yl)phenol sulfonate derivatives

  2025cites this paper
• In silico decoding strategic pathways inhibition by coptisine for halting Alzheimer’s pathology: a mechanistic insight

  2025cites this paper
• Biomarker Detection and Therapy of Parkinson's and Alzheimer's disease using upconversion based approach: A Comprehensive Review.

  2025cites this paper
• Intelligent Transportation System

  2024cites this paper
• Technologically Assisted Multifunctional Smart Bag Based on Solar Energy

  2024cites this paper
• Fabricating Tasks of a Helpful Customer Association Carrying Out Energy-Proficient Yield on a Microgrid Supporting an Extensive Variety of Burden

  2024cites this paper
• Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.

  2024cites this paper
• Aluminium-Metal Oxide (Al2O3) Nanofluid Cooling Technique: Enhancing the Efficiency of Crystalline Silicon Cell Panels

  2024cites this paper
• Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions.

  2024cites this paper
• Automated Alzheimer's disease classification using deep learning models with Soft-NMS and improved ResNet50 integration

  2024cites this paper
• Marine-Derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease.

  2024cites this paper
• Hypoglycemic, anti‐inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. – results of an in vitro study

  2024cites this paper
• Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer’s disease

  2024cites this paper
• Coptisine reverses Alzheimer’s disease by targeting cholinergic and amyloidogenic pathways

  2024cites this paper
• Chromone Hybrids as Interleukin-6 and Acetylcholinesterase Inhibitor for treatment of Alzheimer's Disease: Design, Docking, Synthesis and Evaluation

  2024cites this paper
• Mapping the Distribution Pattern of Startups In Uttarakhand: A Comprehensive Analysis

  2024cites this paper
• Aluminium-Metal Oxide (Al2O3) Performance Evaluation; Utilising Nanofluid Cooling Technology and Artificial Intelligence for Maximum Power Point Tracking of Perovskite Solar Cells

  2024cites this paper
• The Confluence of WSNs and 5G Technologies: A Game-Changing Synergy

  2024cites this paper
• Implementation of Multi-Axis-Based Solar Beam Tracing Methods

  2024cites this paper
• Mechanistic Approach to Immunity and Immunotherapy of Alzheimer's Disease: A Review.

  2024cites this paper
• Evaluation of the Ameliorative Potential of 3,5-bis(2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione against Scopolamine-Induced Alzheimer’s Disease

  2024cites this paper
• Design, synthesis and evaluation of imidazo[1,2-a]pyrazin-8(7H)-one derivatives as acetylcholinesterase inhibitors and antioxidants

  2024cites this paper
• Efficacy of rTMS Combined with Cognitive and Language Training in People Living with Alzheimer’s Disease: A Systematic Review

  2024cites this paper
• Cognition Enhancing Potential of Aqueous Leaf Extract of Amaranthus dubius in Mice

  2023cites this paper
• Carbon nanotube based biosensor: An update

  2023cites this paper
• Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

  2023cites this paper
• Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

  2023cites this paper
• Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil

  2023cites this paper
• Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: A systematic review and Bayesian network meta-analysis.

  2023cites this paper
• Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)

  2023cites this paper
• The multifactorial role of vanillin in amelioration of aluminium chloride and D-galactose induced Alzheimer's disease in mice.

  2023cites this paper
• Animal models of Alzheimer’s disease: preclinical insights and challenges

  2023cites this paper
• Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications

  2023cites this paper
• Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.

  2023cites this paper
• ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer’s disease in APP/PS-1 mice

  2023cites this paper
• Neuroprotective activity of Indonesian traditional herbal medicine: A systematic review

  2023cites this paper
• Novel drug delivery system: Efficacy in Alzheimer’s disease

  2023cites this paper
• Systematic review and PASS assisted prediction of selected phytoconstituents for Alzheimer’s disease

  2023cites this paper
• Research progress on the targets and therapies of Alzheimer’s disease

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• Neuroprotective evaluation of diospyrin against drug-induced Alzheimer's disease.

  2023cites this paper
• Toxicity of arsenic and its effect in Asian villages due to use of dunk cakes as domestic fuel using artificial neural network

  2023cites this paper
• Azilsartan ameliorates aluminium chloride induced Alzheimer’s disease like pathology

  2023cites this paper
• Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology

  2022cites this paper
• A comprehensive review on the prevention and regulation of Alzheimer’s disease by tea and its active ingredients

  2022influential citation
• Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 and anti-apoptotic pathway against scopolamine-induced amnesia in mice.

  2022cites this paper
• Effects of Nicotine Exposure From Tobacco Products and Electronic Cigarettes on the Pathogenesis of Neurological Diseases: Impact on CNS Drug Delivery

  2022cites this paper
• Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments

  2022cites this paper
• Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer’s disease

  2022cites this paper
• Five-Year PTSD Symptom Remission in Two Patients Following Treatment With Rivastigmine.

  2022cites this paper
• Exploring the Formation of Polymers with Anti-Amyloid Properties within the 2′3′-Dihydroxyflavone Autoxidation Process

  2022cites this paper
• Understanding the Relationship Between Age-Related Hearing Loss and Alzheimer’s Disease: A Narrative Review

  2022cites this paper
• An update on the novel and approved drugs for Alzheimer disease

  2022cites this paper
• Psychometric evaluation of the depression anxiety stress scale 8-items (DASS-8)/DASS-12/DASS-21 among family caregivers of patients with dementia

  2022cites this paper
• Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

  2022cites this paper
• Experimentally induced animal models for cognitive dysfunction and Alzheimer's disease

  2022cites this paper
• Experimental Study of Utilization Coconut Fiber as Additional Material and Slag as a Cement Substitution Against Compressive Strength and Split Tensile Strength of Concrete

  2022cites this paper
• A review of therapeutic failures in late-stage clinical trials

  2022cites this paper
• Food for the mind: The journey of probiotics from foods to ANTI-Alzheimer’s disease therapeutics

  2022cites this paper
• Tissue Distribution of Total Flavonoids Extracts of Drynariae Rhizoma in Young and Old Rats by UPLC–MS/MS Determination

  2022cites this paper
• Ligand-based discovery of new potential acetylcholinesterase inhibitors for Alzheimer’s disease treatment

  2022cites this paper
• Design, Synthesis and Bioactivity Evaluation of Coumarin–BMT Hybrids as New Acetylcholinesterase Inhibitors

  2022cites this paper
• Quercetin mitigates scopolamine-induced memory dysfunction: impact on oxidative stress and cholinergic mechanisms

  2021cites this paper
• Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies

  2021cites this paper
• Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy

  2021cites this paper
• Nutraceuticals and their Derived Nano-formulations for the Prevention and Treatment of Alzheimer's disease.

  2021cites this paper
• Suppression of Circadian Timing and Its Impact on the Hippocampus

  2021cites this paper
• Autoxidation Enhances Anti-Amyloid Potential of Flavone Derivatives

  2021cites this paper
• The Treatment of Alzheimer’s Disease through Molecular Docking Studies using Phyltetralin against Kallikrein_6: A Bioinformatic Approach

  2021cites this paper
• Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias

  2021cites this paper
• Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease

  2021cites this paper
• Brain Targeting and Aβ Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice.

  2021cites this paper
• Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease

  2021cites this paper
• Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity

  2021cites this paper
• Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations

  2021cites this paper
• Is Aducanumab for LMICs? Promises and Challenges

  2021cites this paper
• A novel olfactory threshold test for screening cognitive decline among elderly people

  2021cites this paper
• Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease

  2021cites this paper
• Precision Repetitive Transcranial Magnetic Stimulation Over the Left Parietal Cortex Improves Memory in Alzheimer’s Disease: A Randomized, Double-Blind, Sham-Controlled Study

  2021cites this paper
• What’s not in the news headlines or titles of Alzheimer disease articles? #InMice

  2021cites this paper
• Anticholinesterase activities of novel indole-based hydrazide-hydrazone derivatives: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction

  2021cites this paper
• Solid Lipid Nanoparticles In Obesity Management

  2020cites this paper
• Establishment of analytical method for quantification of anti-inflammatory agents co-nanoencapsulated and its application to physicochemical development and characterization of lipid-core nanocapsules

  2020cites this paper
• Natural and synthetic drugs used for the treatment of the dementia.

  2020cites this paper
• Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.

  2020cites this paper
• Current and Future Treatments in Alzheimer Disease: An Update

  2020cites this paper
• Xanthotoxin and umbelliferone attenuate cognitive dysfunction in a streptozotocin‐induced rat model of sporadic Alzheimer's disease: The role of JAK2/STAT3 and Nrf2/HO‐1 signalling pathway modulation

  2020cites this paper
• Osthole ameliorates cognitive impairments via augmenting neuronal population in APP / PS1 transgenic mice.

  2020cites this paper
• Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease

  2020cites this paper
• Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.

  2020cites this paper
• Amaryllidaceae alkaloids and neuronal cell protection

  2020cites this paper
• The two faces of Coprinus comatus—Functional properties and potential hazards

  2020cites this paper
• Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals

  2020cites this paper
• In vitro multifunctionality of phlorotannin extracts from edible Fucus species on targets underpinning neurodegeneration.

  2020cites this paper